SSIA overview
The Social Insurance Investment Authority was established in July 2004 (operations started 2005). It manages Social Insurance Fund, Pensions Fund, and National Health Insurance Fund assets across six investment sectors.
About Us
The medical investment arm of Sudan's Social Insurance Investment Authority.
Corporate Story
Al Dhaman Holding for Medical Investments Co. Ltd (DHMIC) is the dedicated medical investment arm of Sudan's Social Insurance Investment Authority (SSIA). Established under the SSIA umbrella (SSIA founded July 2004; operations from 2005), DHMIC recovers and expands healthcare assets and advances pharmaceutical independence through an integrated hospital network, biomedical and pharma manufacturing, and medical companies and services.
DHMIC role
DHMIC is SSIA's strategic medical investment arm, responsible for healthcare portfolio recovery, asset expansion, and pharmaceutical independence.
Mandate pillars
Five mandate pillars guide how DHMIC stewards social-insurance healthcare assets.
Portfolio recovery
Restore and stabilize healthcare assets for reliable public service delivery.
Asset expansion
Grow hospital, diagnostic, and industrial capacity across priority states.
Quality & governance
Apply investment discipline, clinical standards, and transparent oversight.
Local manufacturing
Build pharmaceutical and medical consumables capacity for national resilience.
Partnerships
Work with ministries, financiers, and global health partners for sustainable impact.
Strategic focus areas
Integrated hospital network
Specialist hospitals and oncology capacity serving communities nationwide.
Biomedical & pharma manufacturing
IV fluids, medicines, syringes, and medical consumables production.
Medical companies & services
Distribution, technology partnerships, training, and clinical support services.
Our Mission
To lead regional health security through local pharmaceutical manufacturing, integrated hospital operations, and sustainable investment returns that strengthen Sudan's health system.
Our Vision
Leadership in regional health security, local pharma manufacturing, and sustainable medical investment returns for Sudan and the wider region.
Our Values
Integrity, transparency, ethical partnership, operational excellence, and patient-centered care.
Executive Leadership
A message from Dr. Ashraf Abdalla (Ashraf Obeid Mohamed Elhadi), Chief Executive Officer. Al Dhaman Holding for Medical Investments Co. Ltd (DHMIC) is the dedicated medical investment arm of Sudan's Social Insurance Investment Authority (SSIA). Our mandate is to manage pension and social-insurance assets through healthcare investment that rehabilitates Sudan's health sector. The group operates three hospitals: Merowe Medical City in Northern State, Sharq El-Nile Specialized Hospital in Khartoum, and Elobyyied International Hospital in Kordofan State. Industrial and commercial subsidiaries include Ain Sudan IV Fluids Factory, Avamed for Medical Industries, Liliam for Pharmaceutical Industries, and Nasif Medical — our distribution and agency arm representing international medical companies. The Daman Medical Training and Research Center supports professional development and applied research across the network. We work in alignment with the Federal Ministry of Health and the Ministry of Human Resources Development and Social Welfare. Our forward programme includes new hospitals and diagnostic centers, and a medical cotton and gauze manufacturing project.
Ownership
DHMIC is a subsidiary of the Social Insurance Investment Authority (SSIA) of Sudan, aligned with national healthcare priorities and with the Federal Ministry of Health and the Ministry of Human Resources Development and Social Welfare.
Governance
The holding oversees investment discipline, operational performance of hospitals and industrial subsidiaries, and compliance with applicable governance standards across the group.
Strategy
DHMIC expands hospital and diagnostic capacity, deepens local manufacturing of pharmaceuticals, IV fluids, and medical consumables, and builds exclusive long-term technology partnerships through Nasif Medical, while developing the Daman Medical Training and Research Center.